GlaxoSmithKline
NYSE: GSK
$29.43
+$0.07 (+0.2%)
Closing price September 30, 2022
Friday's top analyst upgrades and downgrades included Chipotle Mexican Grill, CrowdStrike, First Solar, Fortinet, Franklin Resources, GSK, Intel, Nvidia, Shoals Technologies, Spirit AeroSystems,...
24 days ago
Last Updated: 24 days ago
Friday's top analyst upgrades and downgrades included Alcoa, Blue Apron, Brixmor Property, Enterprise Products Partners, FIGS, GSK, Healthcare Realty Trust, Nordstrom, Range Resources, Southwestern...
2 months ago
Last Updated: 2 months ago
Monday's top analyst upgrades and downgrades included Chewy, Cloudflare, Coca-Cola, Doximity, Ideanomics, GlaxoSmithKline, Micron Technology, SoFi Technologies, Teladoc Health, Twitter and Walmart.
7 months ago
Last Updated: 7 months ago
Friday afternoon's analyst upgrades and downgrades included BigCommerce, Citrix, GlaxoSmithKline, Nikola, Regeneron, Shake Shack and more.
10 months ago
Thursday’s top analyst upgrades and downgrades included Analog Devices, Activision Blizzard, BP, Clorox, EA, MGM PayPal, Square and more.
1 year ago
Last Updated: 1 year ago
24/7 Wall St. looks at some big analyst calls that we have seen so far on Tuesday, including Alexion, DraftKings, Inovio, Netflix, Snowflake and more.
1 year ago
Thursday's top analyst upgrades and downgrades included Apple, Best Buy, Electronic Arts, FireEye, Match, PayPal, Qualcomm and ViacomCBS.
1 year ago
Last Updated: 1 year ago
Wednesday's top analyst upgrades and downgrades included Altria, Boeing, Coca-Cola, GlaxoSmithKline, Halliburton, Kroger, Netflix and Pioneer Natural Resources.
1 year ago
Last Updated: 1 year ago
Vir Biotechnology shares jumped on Tuesday after the firm announced that it would be expanding its late-stage COVID-19 study in conjunction with GlaxoSmithKline.
1 year ago
Many health care products become much more popular because of endorsements and advertising efforts. It is a longstanding practice that has come under fire by both political parties in the United...
1 year ago
Last Updated: 1 year ago
Nvidia has announced it will partner with GlaxoSmithKline to apply its artificial intelligence and supercomputers for the drug and vaccine discovery process.
1 year ago
GlaxoSmithKline has announced that it is acquiring a 10% stake in the German biopharma firm CureVac.
2 years ago
There are still a lot of questions for Amarin must figure out before it gets back on track. For investors, the question is whether it is the market recovery that is lifting the stock instead of the...
2 years ago
Amarin stock was absolutely crushed at the tail end of March, and now the company is dealing with the fallout. Investors will be asking a lot of tough questions. Namely, is Amarin viable going...
2 years ago
Co-Diagnostics is on many shortlists of companies with partial medical solutions to slow the coronavirus outbreak. Investors have been on a roller-coaster ride. Is the stock ready to run?
2 years ago